Grriz JL, Soler MJ, Navarro-Gonzlez JF, Garca-Carro C, Puchades MJ, DMarco L, Martnez Castelao A, Fernndez-Fernndez B, Ortiz A, Grriz-Zambrano C, Navarro-Prez J, Gorgojo-Martinez JJ (2020) GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists
It is always best to consult with a healthcare provider before starting any new weight loss regimen
These types of experiences show how differently people may respond, and they highlight the need for more research into how GLP-1 medications affect the brain and behavior
This is the same pathway used in semaglutide, liraglutide, and tirzepatide
Inpatient treatment may be required when a person needs medical and/or psychiatric stabilisation, nutritional rehabilitation and/or more intensive treatment and support